Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial

Author:

Holland Thomas L.,Ginde Adit A.,Paredes Roger,Murray Thomas A.,Engen Nicole,Grandits Greg,Vekstein Andrew,Ivey Noel,Mourad Ahmad,Sandkovsky Uriel,Gottlieb Robert L.,Berhe Mezgebe,Jain Mamta K.,Marines-Price Rubria,Agbor Agbor Barbine Tchamba,Mateu Lourdes,España-Cueto Sergio,Lladós Gemma,Mylonakis Eleftherios,Rogers Ralph,Shehadeh Fadi,Filbin Michael R.,Hibbert Kathryn A.,Kim Kami,Tran Thanh,Morris Peter E.,Cassity Evan P.,Trautner Barbara,Pandit Lavannya M.,Knowlton Kirk U.,Leither Lindsay,Matthay Michael A.,Rogers Angela J.,Drake Wonder,Jones Beatrice,Poulakou Garyfallia,Syrigos Konstantinos N.,Fernández-Cruz Eduardo,Di Natale Marisa,Almasri Eyad,Balerdi-Sarasola Leire,Bhagani Sanjay R.,Boyle Katherine L.,Casey Jonathan D.,Chen Peter,Douin David J.,Files D. Clark,Günthard Huldrych F.,Hite R. Duncan,Hyzy Robert C.,Khan Akram,Kibirige Moses,Kidega Robert,Kimuli Ivan,Kiweewa Francis,Jensen Jens-Ulrik,Leshnower Bradley G.,Lutaakome Joseph K.,Manian Prasad,Menon Vidya,Morales-Rull Jose Luis,O'Mahony D. Shane,Overcash J. Scott,Ramachandruni Srikant,Steingrub Jay S.,Taha Hassan S.,Waters Michael,Young Barnaby E.,Phillips Andrew N.,Murray Daniel D.,Jensen Tomas O.,Padilla Maria L.,Sahner David,Shaw-Saliba Katy,Dewar Robin L.,Teitelbaum Marc,Natarajan Ven,Rehman M. Tauseef,Pett Sarah,Hudson Fleur,Touloumi Giota,Brown Samuel M.,Self Wesley H.,Chang Christina C.,Sánchez Adriana,Weintrob Amy C.,Hatlen Timothy,Grund Birgit,Sharma Shweta,Reilly Cavan S.,Garbes Pedro,Esser Mark T.,Templeton Alison,Babiker Abdel G.,Davey Victoria J.,Gelijns Annetine C.,Higgs Elizabeth S.,Kan Virginia,Matthews Gail,Thompson B. Taylor,Neaton James D.,Lane H. Clifford,Lundgren Jens D.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference32 articles.

1. REGEN-COV Antibody combination and outcomes in outpatients with Covid-19;Weinreich;N Engl J Med,2021

2. Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab;Gupta;N Engl J Med,2021

3. Bamlanivimab plus etesevimab in mild or moderate Covid-19;Dougan;N Engl J Med,2021

4. Letter of authorization for emergency use of EVUSHELD (tixagevimab and cilgavimab),2022

5. Subcutaneous REGEN-COV antibody combination to prevent Covid-19;O'Brien;N Engl J Med,2021

Cited by 78 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3